Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers
Inappropriate prescribing is a rising threat to the health of Medicare beneficiaries and a drain on Medicare’s finances. In this study we used a randomized controlled trial approach to evaluate a low-cost, light-touch intervention aimed at reducing the inappropriate provision of Schedule II controll...
Main Authors: | Sacarny, A., Yokum, D., Agrawal, S., Finkelstein, Amy |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Economics |
Format: | Article |
Language: | en_US |
Published: |
Project Hope
2016
|
Online Access: | http://hdl.handle.net/1721.1/105912 https://orcid.org/0000-0002-9941-6684 |
Similar Items
-
The National Overprescribing Review for England - another step forward?
by: Treadwell, J
Published: (2021) -
The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D *
by: Einav, Liran, et al.
Published: (2018) -
Mandatory Medicare Bundled Payment Program for Lower Extremity Joint Replacement and Discharge to Institutional Postacute Care
by: Finkelstein, Amy, et al.
Published: (2020) -
Physician response to medicare fee regulations
by: Yip, Winnie Chi-man
Published: (2005) -
On the Complexity of Theory Curbing
by: Eiter, T, et al.
Published: (2000)